{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T00:56:57Z","timestamp":1793235417489,"version":"4.5.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2018,11,29]],"date-time":"2018-11-29T00:00:00Z","timestamp":1543449600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Intern Emerg Med"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1007\/s11739-018-1991-y","type":"journal-article","created":{"date-parts":[[2018,11,29]],"date-time":"2018-11-29T04:10:47Z","timestamp":1543464647000},"page":"645-652","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":144,"title":["Vascular Beh\u00e7et\u2019s syndrome: an update"],"prefix":"10.1007","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9575-8321","authenticated-orcid":false,"given":"Giacomo","family":"Emmi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Bettiol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Silvestri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerardo","family":"Di Scala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Becatti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Fiorillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenico","family":"Prisco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,11,29]]},"reference":[{"key":"1991_CR1","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1586\/14779072.2013.836449","volume":"11","author":"E Silvestri","year":"2013","unstructured":"Silvestri E, Emmi G, Prisco D (2013) Vascular Beh\u00e7et\u2019s disease: new insights in the management of thrombosis. Expert Rev Cardiovasc Ther 11:1583\u20131585. \n                              https:\/\/doi.org\/10.1586\/14779072.2013.836449","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"1991_CR2","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s12016-012-8319-x","volume":"43","author":"H Yazici","year":"2012","unstructured":"Yazici H, Ugurlu S, Seyahi E (2012) Beh\u00e7et syndrome: is it one condition? Clin Rev Allergy Immunol 43:275\u2013280. \n                              https:\/\/doi.org\/10.1007\/s12016-012-8319-x","journal-title":"Clin Rev Allergy Immunol"},{"key":"1991_CR3","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1111\/jdv.12107","volume":"28","author":"S Assaad-Khalil","year":"2014","unstructured":"International Team for the Revision of the International Criteria for Beh\u00e7et\u2019s Disease (ITR-ICBD) F, Assaad-Khalil S, Calamia KT et al (2014) The International Criteria for Beh\u00e7et\u2019s Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria. J Eur Acad Dermatol Venereol 28:338\u2013347. \n                              https:\/\/doi.org\/10.1111\/jdv.12107","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1991_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/art.37715","volume":"65","author":"JC Jennette","year":"2013","unstructured":"Jennette JC, Falk RJ, Bacon PA et al (2013) 2012 revised international chapel hill consensus conference nomenclature of vasculitides. Arthritis Rheum 65:1\u201311. \n                              https:\/\/doi.org\/10.1002\/art.37715","journal-title":"Arthritis Rheum"},{"key":"1991_CR5","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1503\/cmaj.061136","volume":"176","author":"DR McDonald","year":"2007","unstructured":"McDonald DR, Lee C, Fowler RA, Abuhaleeqa K (2007) Behcet\u2019s disease. CMAJ 176:1273\u20131274. \n                              https:\/\/doi.org\/10.1503\/cmaj.061136","journal-title":"CMAJ"},{"key":"1991_CR6","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/S0039-6257(01)00275-2","volume":"46","author":"SR Boyd","year":"2001","unstructured":"Boyd SR, Young S, Lightman S (2001) Immunopathology of the noninfectious posterior and intermediate uveitides. Surv Ophthalmol 46:209\u2013233","journal-title":"Surv Ophthalmol"},{"key":"1991_CR7","first-page":"S91","volume":"27","author":"S Hirohata","year":"2009","unstructured":"Hirohata S, Kikuchi H (2009) Histopathology of the ruptured pulmonary artery aneurysm in a patient with Beh\u00e7et\u2019s disease. Clin Exp Rheumatol 27:S91\u2013S95","journal-title":"Clin Exp Rheumatol"},{"key":"1991_CR8","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1046\/j.1365-4362.1998.00474.x","volume":"37","author":"T Ergun","year":"1998","unstructured":"Ergun T, G\u00fcrb\u00fcz O, Harvell J et al (1998) The histopathology of pathergy: a chronologic study of skin hyperreactivity in Beh\u00e7et\u2019s disease. Int J Dermatol 37:929\u2013933","journal-title":"Int J Dermatol"},{"key":"1991_CR9","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1136\/bjo.87.9.1175","volume":"87","author":"DH Verity","year":"2003","unstructured":"Verity DH, Wallace GR, Vaughan RW, Stanford MR (2003) Beh\u00e7et\u2019s disease: from Hippocrates to the third millennium. Br J Ophthalmol 87:1175\u20131183","journal-title":"Br J Ophthalmol"},{"key":"1991_CR10","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1007\/s11739-013-1036-5","volume":"9","author":"G Emmi","year":"2014","unstructured":"Emmi G, Silvestri E, Squatrito D et al (2014) Beh\u00e7et\u2019s syndrome pathophysiology and potential therapeutic targets. Intern Emerg Med 9:257\u2013265. \n                              https:\/\/doi.org\/10.1007\/s11739-013-1036-5","journal-title":"Intern Emerg Med"},{"key":"1991_CR11","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.autrev.2014.11.009","volume":"14","author":"C Consolandi","year":"2015","unstructured":"Consolandi C, Turroni S, Emmi G et al (2015) Beh\u00e7et\u2019s syndrome patients exhibit specific microbiome signature. Autoimmun Rev 14:269\u2013276. \n                              https:\/\/doi.org\/10.1016\/j.autrev.2014.11.009","journal-title":"Autoimmun Rev"},{"key":"1991_CR12","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1002\/acn3.538","volume":"5","author":"A Aldinucci","year":"2018","unstructured":"Aldinucci A, Bonechi E, Biagioli T et al (2018) CSF\/serum matrix metallopeptidase-9 ratio discriminates neuro Beh\u00e7et from multiple sclerosis. Ann Clin Transl Neurol 5:493\u2013498. \n                              https:\/\/doi.org\/10.1002\/acn3.538","journal-title":"Ann Clin Transl Neurol"},{"key":"1991_CR13","doi-asserted-by":"publisher","first-page":"e5516","DOI":"10.1097\/MD.0000000000005516","volume":"95","author":"G Emmi","year":"2016","unstructured":"Emmi G, Silvestri E, Della Bella C et al (2016) Cytotoxic Th1 and Th17 cells infiltrate the intestinal mucosa of Behcet patients and exhibit high levels of TNF-\u03b1 in early phases of the disease. Medicine 95:e5516. \n                              https:\/\/doi.org\/10.1097\/MD.0000000000005516\n                              \n                           \n                           (Baltimore)","journal-title":"Medicine"},{"key":"1991_CR14","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.2174\/138161212799504731","volume":"18","author":"K Aksu","year":"2012","unstructured":"Aksu K, Donmez A, Keser G (2012) Inflammation-induced thrombosis: mechanisms, disease associations and management. Curr Pharm Des 18:1478\u20131493","journal-title":"Curr Pharm Des"},{"key":"1991_CR15","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s12959-015-0047-z","volume":"13","author":"G Emmi","year":"2015","unstructured":"Emmi G, Silvestri E, Squatrito D et al (2015) Thrombosis in vasculitis: from pathogenesis to treatment. Thromb J 13:15. \n                              https:\/\/doi.org\/10.1186\/s12959-015-0047-z","journal-title":"Thromb J"},{"key":"1991_CR16","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/S0140-6736(75)80031-6","volume":"2","author":"N Matsumura","year":"1975","unstructured":"Matsumura N, Mizushima Y (1975) Leucocyte movement and colchicine treatment in Behcet\u2019s disease. Lancet 2:813 (London, England)","journal-title":"Lancet"},{"key":"1991_CR17","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1001\/archderm.140.5.570","volume":"140","author":"T Kawakami","year":"2004","unstructured":"Kawakami T, Ohashi S, Kawa Y et al (2004) Elevated serum granulocyte colony-stimulating factor levels in patients with active phase of sweet syndrome and patients with active behcet disease: implication in neutrophil apoptosis dysfunction. Arch Dermatol 140:570\u2013574. \n                              https:\/\/doi.org\/10.1001\/archderm.140.5.570","journal-title":"Arch Dermatol"},{"key":"1991_CR18","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1136\/thorax.56.7.572","volume":"56","author":"F Erkan","year":"2001","unstructured":"Erkan F, G\u00fcl A, Tasali E (2001) Pulmonary manifestations of Beh\u00e7et\u2019s disease. Thorax 56:572\u2013578","journal-title":"Thorax"},{"key":"1991_CR19","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1038\/nri3024","volume":"11","author":"A Mantovani","year":"2011","unstructured":"Mantovani A, Cassatella MA, Costantini C, Jaillon S (2011) Neutrophils in the activation and regulation of innate and adaptive immunity. Nat Rev Immunol 11:519\u2013531. \n                              https:\/\/doi.org\/10.1038\/nri3024","journal-title":"Nat Rev Immunol"},{"key":"1991_CR20","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1161\/CIRCULATIONAHA.115.017738","volume":"133","author":"M Becatti","year":"2016","unstructured":"Becatti M, Emmi G, Silvestri E et al (2016) Neutrophil activation promotes fibrinogen oxidation and thrombus formation in Beh\u00e7et disease. Circulation 133:302\u2013311. \n                              https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.115.017738","journal-title":"Circulation"},{"key":"1991_CR21","doi-asserted-by":"publisher","first-page":"h2039","DOI":"10.1136\/bmj.h2039","volume":"350","author":"H Nasr","year":"2015","unstructured":"Nasr H, Scriven JM (2015) Superficial thrombophlebitis (superficial venous thrombosis). BMJ 350:h2039. \n                              https:\/\/doi.org\/10.1136\/bmj.h2039","journal-title":"BMJ"},{"key":"1991_CR22","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s12959-015-0039-z","volume":"13","author":"SA Sarr","year":"2015","unstructured":"Sarr SA, Fall PD, Mboup MC et al (2015) Superior vena cava syndrome revealing a Beh\u00e7et\u2019s disease. Thromb J 13:7. \n                              https:\/\/doi.org\/10.1186\/s12959-015-0039-z","journal-title":"Thromb J"},{"key":"1991_CR23","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1016\/S0046-8177(85)80250-1","volume":"16","author":"S Lakhanpal","year":"1985","unstructured":"Lakhanpal S, Tani K, Lie JT et al (1985) Pathologic features of Beh\u00e7et\u2019s syndrome: a review of Japanese autopsy registry data. Hum Pathol 16:790\u2013795","journal-title":"Hum Pathol"},{"key":"1991_CR24","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1016\/j.amjmed.2004.05.027","volume":"117","author":"V Hamuryudan","year":"2004","unstructured":"Hamuryudan V, Er T, Seyahi E et al (2004) Pulmonary artery aneurysms in Beh\u00e7et syndrome. Am J Med 117:867\u2013870. \n                              https:\/\/doi.org\/10.1016\/j.amjmed.2004.05.027","journal-title":"Am J Med"},{"key":"1991_CR25","doi-asserted-by":"publisher","first-page":"2806","DOI":"10.1002\/art.27568","volume":"62","author":"D Saadoun","year":"2010","unstructured":"Saadoun D, Wechsler B, Desseaux K et al (2010) Mortality in Beh\u00e7et\u2019s disease. Arthritis Rheum 62:2806\u20132812. \n                              https:\/\/doi.org\/10.1002\/art.27568","journal-title":"Arthritis Rheum"},{"key":"1991_CR26","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/S0007-0971(59)80106-6","volume":"53","author":"JP Hughes","year":"1959","unstructured":"Hughes JP, Stovin PG (1959) Segmental pulmonary artery aneurysms with peripheral venous thrombosis. Br J Dis Chest 53:19\u201327","journal-title":"Br J Dis Chest"},{"key":"1991_CR27","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/1750-1172-6-15","volume":"6","author":"U Khalid","year":"2011","unstructured":"Khalid U, Saleem T (2011) Hughes\u2013Stovin syndrome. Orphanet J Rare Dis 6:15. \n                              https:\/\/doi.org\/10.1186\/1750-1172-6-15","journal-title":"Orphanet J Rare Dis"},{"key":"1991_CR28","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1136\/annrheumdis-2018-213225","volume":"77","author":"G Hatemi","year":"2018","unstructured":"Hatemi G, Christensen R, Bang D et al (2018) 2018 update of the EULAR recommendations for the management of Beh\u00e7et\u2019s syndrome. Ann Rheum Dis 77:808\u2013818. \n                              https:\/\/doi.org\/10.1136\/annrheumdis-2018-213225","journal-title":"Ann Rheum Dis"},{"key":"1991_CR29","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1080\/13543784.2016.1181751","volume":"25","author":"A Vitale","year":"2016","unstructured":"Vitale A, Rigante D, Lopalco G et al (2016) New therapeutic solutions for Beh\u00e7et\u2019s syndrome. Expert Opin Investig Drugs 25:827\u2013840. \n                              https:\/\/doi.org\/10.1080\/13543784.2016.1181751","journal-title":"Expert Opin Investig Drugs"},{"key":"1991_CR30","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s10067-007-0685-z","volume":"27","author":"JK Ahn","year":"2008","unstructured":"Ahn JK, Lee YS, Jeon CH et al (2008) Treatment of venous thrombosis associated with Behcet\u2019s disease: immunosuppressive therapy alone versus immunosuppressive therapy plus anticoagulation. Clin Rheumatol 27:201\u2013205. \n                              https:\/\/doi.org\/10.1007\/s10067-007-0685-z","journal-title":"Clin Rheumatol"},{"key":"1991_CR31","doi-asserted-by":"publisher","first-page":"e494","DOI":"10.1097\/MD.0000000000000494","volume":"94","author":"F Alibaz-Oner","year":"2015","unstructured":"Alibaz-Oner F, Karadeniz A, Ylmaz S et al (2015) Beh\u00e7et disease with vascular involvement. Medicine 94:e494. \n                              https:\/\/doi.org\/10.1097\/MD.0000000000000494\n                              \n                           \n                           (Baltimore)","journal-title":"Medicine"},{"key":"1991_CR32","doi-asserted-by":"publisher","first-page":"2753","DOI":"10.1002\/art.34450","volume":"64","author":"AC Desbois","year":"2012","unstructured":"Desbois AC, Wechsler B, Resche-Rigon M et al (2012) Immunosuppressants reduce venous thrombosis relapse in Beh\u00e7et\u2019s disease. Arthritis Rheum 64:2753\u20132760. \n                              https:\/\/doi.org\/10.1002\/art.34450","journal-title":"Arthritis Rheum"},{"key":"1991_CR33","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1002\/art.40531","volume":"70","author":"G Emmi","year":"2018","unstructured":"Emmi G, Vitale A, Silvestri E et al (2018) Adalimumab-based treatment versus DMARDs for venous thrombosis in Beh\u00e7et syndrome. A retrospective study of 70 patients with vascular involvement. Arthritis Rheumatol 70:1500\u20131507. \n                              https:\/\/doi.org\/10.1002\/art.40531","journal-title":"Arthritis Rheumatol"},{"key":"1991_CR34","doi-asserted-by":"publisher","first-page":"292","DOI":"10.5152\/akd.2014.5042","volume":"14","author":"A Hamzaoui","year":"2014","unstructured":"Hamzaoui A, Fatima J, Thouraya BS et al (2014) Vena cava thrombosis in Beh\u00e7et\u2019s disease. Anadolu Kardiyol Derg 14:292\u2013293. \n                              https:\/\/doi.org\/10.5152\/akd.2014.5042","journal-title":"Anadolu Kardiyol Derg"},{"key":"1991_CR35","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/j.semarthrit.2014.10.014","volume":"44","author":"E Seyahi","year":"2015","unstructured":"Seyahi E, Caglar E, Ugurlu S et al (2015) An outcome survey of 43 patients with Budd\u2013Chiari syndrome due to Beh\u00e7et\u2019s syndrome followed up at a single, dedicated center. Semin Arthritis Rheum 44:602\u2013609. \n                              https:\/\/doi.org\/10.1016\/j.semarthrit.2014.10.014","journal-title":"Semin Arthritis Rheum"},{"key":"1991_CR36","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1093\/rheumatology\/kem103","volume":"46","author":"E Seyahi","year":"2007","unstructured":"Seyahi E, Hamuryudan V, Hatemi G et al (2007) Infliximab in the treatment of hepatic vein thrombosis (Budd\u2013Chiari syndrome) in three patients with Behcet\u2019s syndrome. Rheumatology 46:1213\u20131214. \n                              https:\/\/doi.org\/10.1093\/rheumatology\/kem103\n                              \n                           \n                           (Oxford)","journal-title":"Rheumatology"},{"key":"1991_CR37","doi-asserted-by":"publisher","first-page":"148","DOI":"10.4081\/reumatismo.2016.887","volume":"68","author":"I Ben Ghorbel","year":"2016","unstructured":"Ben Ghorbel I, Belfeki N, Houman MH (2016) Intracardiac thrombus in Beh\u00e7et\u2019s disease. Reumatismo 68:148\u2013153. \n                              https:\/\/doi.org\/10.4081\/reumatismo.2016.887","journal-title":"Reumatismo"},{"key":"1991_CR38","doi-asserted-by":"publisher","first-page":"2501","DOI":"10.1007\/s10067-015-3161-1","volume":"35","author":"H Wang","year":"2016","unstructured":"Wang H, Guo X, Tian Z et al (2016) Intracardiac thrombus in patients with Behcet\u2019s disease: clinical correlates, imaging features, and outcome: a retrospective, single-center experience. Clin Rheumatol 35:2501\u20132507. \n                              https:\/\/doi.org\/10.1007\/s10067-015-3161-1","journal-title":"Clin Rheumatol"},{"key":"1991_CR39","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/key279","author":"D Prisco","year":"2018","unstructured":"Prisco D, Silvestri E, Di Scala G, Emmi G (2018) Beh\u00e7et\u2019s disease as a cause of cerebral sinus vein thrombosis: an emerging role. Rheumatology. \n                              https:\/\/doi.org\/10.1093\/rheumatology\/key279\n                              \n                           \n                           (Oxford)","journal-title":"Rheumatology"},{"key":"1991_CR40","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1093\/rheumatology\/key153","volume":"55","author":"D Uluduz","year":"2018","unstructured":"Uluduz D, Midi I, Duman T et al (2018) Beh\u00e7et\u2019s disease as a causative factor of cerebral venous sinus thrombosis: subgroup analysis of data from the VENOST study. Rheumatology 55:464. \n                              https:\/\/doi.org\/10.1093\/rheumatology\/key153\n                              \n                           \n                           (Oxford)","journal-title":"Rheumatology"},{"key":"1991_CR41","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1002\/art.24393","volume":"61","author":"D Saadoun","year":"2009","unstructured":"Saadoun D, Wechsler B, Resche-Rigon M et al (2009) Cerebral venous thrombosis in Beh\u00e7et\u2019s disease. Arthritis Rheum 61:518\u2013526. \n                              https:\/\/doi.org\/10.1002\/art.24393","journal-title":"Arthritis Rheum"},{"key":"1991_CR42","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s10067-017-3718-2","volume":"37","author":"J Shi","year":"2018","unstructured":"Shi J, Huang X, Li G et al (2018) Cerebral venous sinus thrombosis in Beh\u00e7et\u2019s disease: a retrospective case-control study. Clin Rheumatol 37:51\u201357. \n                              https:\/\/doi.org\/10.1007\/s10067-017-3718-2","journal-title":"Clin Rheumatol"},{"key":"1991_CR43","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1097\/MD.0b013e318242ff37","volume":"91","author":"E Seyahi","year":"2012","unstructured":"Seyahi E, Melikoglu M, Akman C et al (2012) Pulmonary artery involvement and associated lung disease in Beh\u00e7et disease: a series of 47 patients. Medicine 91:35\u201348. \n                              https:\/\/doi.org\/10.1097\/MD.0b013e318242ff37\n                              \n                           \n                           (Baltimore)","journal-title":"Medicine"},{"key":"1991_CR44","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1111\/crj.12153","volume":"9","author":"X Zhang","year":"2015","unstructured":"Zhang X, Dai H, Ma Z et al (2015) Pulmonary involvement in patients with Beh\u00e7et\u2019s disease: report of 15 cases. Clin Respir J 9:414\u2013422. \n                              https:\/\/doi.org\/10.1111\/crj.12153","journal-title":"Clin Respir J"},{"key":"1991_CR45","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1007\/s11739-018-1863-5","volume":"13","author":"GM Rossi","year":"2018","unstructured":"Rossi GM, Emmi G, Vaglio A (2018) Hemoptysis in Beh\u00e7et\u2019s syndrome: from bedside to bench? Intern Emerg Med 13:467\u2013469. \n                              https:\/\/doi.org\/10.1007\/s11739-018-1863-5","journal-title":"Intern Emerg Med"},{"key":"1991_CR46","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1007\/s11739-018-1817-y","volume":"13","author":"G Voiriot","year":"2018","unstructured":"Voiriot G, Parrot A, Antoine M et al (2018) Transcatheter embolotherapy of pulmonary artery aneurysms as emergency treatment of hemoptysis in Behcet patients: experience of a referral center and a review of the literature. Intern Emerg Med 13:491\u2013500. \n                              https:\/\/doi.org\/10.1007\/s11739-018-1817-y","journal-title":"Intern Emerg Med"},{"key":"1991_CR47","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.semarthrit.2015.06.008","volume":"45","author":"V Hamuryudan","year":"2015","unstructured":"Hamuryudan V, Seyahi E, Ugurlu S et al (2015) Pulmonary artery involvement in Beh\u00e7et\u05f3s syndrome: effects of anti-Tnf treatment. Semin Arthritis Rheum 45:369\u2013373. \n                              https:\/\/doi.org\/10.1016\/j.semarthrit.2015.06.008","journal-title":"Semin Arthritis Rheum"},{"key":"1991_CR48","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1093\/rheumatology\/33.1.48","volume":"33","author":"V Hamuryudan","year":"1994","unstructured":"Hamuryudan V, Yurdakul S, Moral F et al (1994) Pulmonary arterial aneurysms in Beh\u00e7et\u2019s syndrome: a report of 24 cases. Rheumatology 33:48\u201351. \n                              https:\/\/doi.org\/10.1093\/rheumatology\/33.1.48","journal-title":"Rheumatology"},{"key":"1991_CR49","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1159\/000101954","volume":"75","author":"O Uzun","year":"2008","unstructured":"Uzun O, Erkan L, Akpolat I et al (2008) Pulmonary involvement in Beh\u00e7et\u2019s disease. Respiration 75:310\u2013321. \n                              https:\/\/doi.org\/10.1159\/000101954","journal-title":"Respiration"},{"key":"1991_CR50","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.ejvs.2015.07.011","volume":"50","author":"O Balcioglu","year":"2015","unstructured":"Balcioglu O, Ertugay S, Bozkaya H et al (2015) Endovascular repair and adjunctive immunosuppressive therapy of aortic involvement in Beh\u00e7et\u2019s disease. Eur J Vasc Endovasc Surg 50:593\u2013598. \n                              https:\/\/doi.org\/10.1016\/j.ejvs.2015.07.011","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"1991_CR51","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1583\/1545-1550(2003)010<0075:ETCWIT>2.0.CO;2","volume":"10","author":"B Kwon Koo","year":"2003","unstructured":"Kwon Koo B, Shim W-H, Yoon Y-S et al (2003) Endovascular therapy combined with immunosuppressive treatment for pseudoaneurysms in patients with Beh\u00e7et\u2019s disease. J Endovasc Ther 10:75\u201380. \n                              https:\/\/doi.org\/10.1177\/152660280301000116","journal-title":"J Endovasc Ther"},{"key":"1991_CR52","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.berh.2016.08.002","volume":"30","author":"E Seyahi","year":"2016","unstructured":"Seyahi E (2016) Beh\u00e7et\u2019s disease: how to diagnose and treat vascular involvement. Best Pract Res Clin Rheumatol 30:279\u2013295. \n                              https:\/\/doi.org\/10.1016\/j.berh.2016.08.002","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"1991_CR53","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1007\/s10067-016-3417-4","volume":"36","author":"A Vitale","year":"2017","unstructured":"Vitale A, Emmi G, Lopalco G et al (2017) Adalimumab effectiveness in Beh\u00e7et\u2019s disease: short and long-term data from a multicenter retrospective observational study. Clin Rheumatol 36:451\u2013455. \n                              https:\/\/doi.org\/10.1007\/s10067-016-3417-4","journal-title":"Clin Rheumatol"},{"key":"1991_CR54","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1007\/s10067-018-4092-4","volume":"37","author":"C Fabiani","year":"2018","unstructured":"Fabiani C, Vitale A, Rigante D et al (2018) Predictors of sustained clinical response in patients with Beh\u00e7et\u2019s disease-related uveitis treated with infliximab and adalimumab. Clin Rheumatol 37:1715\u20131720. \n                              https:\/\/doi.org\/10.1007\/s10067-018-4092-4","journal-title":"Clin Rheumatol"},{"key":"1991_CR55","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1136\/bjophthalmol-2017-310733","volume":"102","author":"C Fabiani","year":"2018","unstructured":"Fabiani C, Sota J, Vitale A et al (2018) Cumulative retention rate of adalimumab in patients with Beh\u00e7et\u2019s disease-related uveitis: a 4-year follow-up study. Br J Ophthalmol 102:637\u2013641. \n                              https:\/\/doi.org\/10.1136\/bjophthalmol-2017-310733","journal-title":"Br J Ophthalmol"},{"key":"1991_CR56","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s10067-016-3480-x","volume":"36","author":"C Fabiani","year":"2017","unstructured":"Fabiani C, Vitale A, Emmi G et al (2017) Efficacy and safety of adalimumab in Beh\u00e7et\u2019s disease-related uveitis: a multicenter retrospective observational study. Clin Rheumatol 36:183\u2013189. \n                              https:\/\/doi.org\/10.1007\/s10067-016-3480-x","journal-title":"Clin Rheumatol"},{"key":"1991_CR57","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1080\/14397595.2017.1285857","volume":"27","author":"G Lopalco","year":"2017","unstructured":"Lopalco G, Emmi G, Gentileschi S et al (2017) Certolizumab Pegol treatment in Behcet\u2019s disease with different organ involvement: a multicenter retrospective observational study. Mod Rheumatol 27:1031\u20131035. \n                              https:\/\/doi.org\/10.1080\/14397595.2017.1285857","journal-title":"Mod Rheumatol"},{"key":"1991_CR58","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s10067-018-4302-0","volume":"5","author":"A Vitale","year":"2018","unstructured":"Vitale A, Emmi G, Lopalco G et al (2018) Correction to: long-term efficacy and safety of golimumab in the treatment of multirefractory Beh\u00e7et\u2019s disease. Clin Rheumatol 5:123. \n                              https:\/\/doi.org\/10.1007\/s10067-018-4302-0","journal-title":"Clin Rheumatol"}],"container-title":["Internal and Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11739-018-1991-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11739-018-1991-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11739-018-1991-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,28]],"date-time":"2019-11-28T19:30:49Z","timestamp":1574969449000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11739-018-1991-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,29]]},"references-count":58,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["1991"],"URL":"https:\/\/doi.org\/10.1007\/s11739-018-1991-y","relation":{},"ISSN":["1828-0447","1970-9366"],"issn-type":[{"value":"1828-0447","type":"print"},{"value":"1970-9366","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,29]]},"assertion":[{"value":"3 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The author declares that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statement of human and animal rights"}},{"value":"Informed consent is not applicable to this study (review).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}